8:55 am Chair’s Opening Remarks
Driving for Better Patient Experience Throughout Patient Journey to Optimize for Patient Retention
9:00 am Maximizing Patient Education & Collaboration During Research & Development to Support Patient Preparation to Receive a Therapy
Synopsis
- Educating patients on the science, risks, and benefits of cell or gene therapies to guide patients to a well-informed decision
- Fostering transparent conversations to involve patients in clinical trial design and treatment decisions
- Highlighting the role of patient feedback to shape ethical and accessible R&D pathways
9:30 am Optimizing Healthcare Readiness & Treatment Experiences to Assist Patients Throughout Treatment Journey
Synopsis
- Addressing patient concerns and maintaining open communication during treatment to support patients through their challenges
- Revealing system gaps in healthcare stakeholders like payers and healthcare professionals to establish sustainable adoption of a therapy
- Developing innovative access models to ensure affordability and equitable delivery of therapies
10:00 am Morning Refreshment Break & Speed Networking
Utilizing Patient Involvement to Achieve Regulatory Approval
11:00 am Roundtable Discussion: Educating Patients on the Next Steps Following the Current US Health Agency Layoffs to Manage Patient Expectations
Synopsis
- Addressing the current layoffs occurring at agencies of the Health and Human Services like the FDA to introduce regulatory challenges
- Predicting the potential patient engagement issues this will cause to prepare biopharma and patient groups for new solutions
- Developing strategies to inform patients on the current issues to manage patients understanding and expectations
12:00 pm Lunch Break and Networking
1:15 pm Discussion Session: Debating Whether Patient Organization Leaders Should be Involved in Regulatory Meetings to Optimize Patient Transparency
Synopsis
- Comparing different views of early patient groups implementation during regulatory meetings to utilize patient voices
- Assessing the risks and benefits of early patient implementation to evaluate its necessity
- Reviewing the process of how patient insights are passed to regulatory bodies to ensure clear translation of patients’ needs
2:15 pm Afternoon Break & Networking
Exploring the Innovative Methods of Cell & Gene Therapy Education to Improve Patient Awareness
2:45 pm Case Study: Demonstrating New Digital Education Tools for CAR-T to Support Shared Decision Making in Cell Therapy
Synopsis
- Exploring the different challenges of educating CAR-T to optimize for improved CAR-T specific educational material
- Showcase the recurring challenges faced by prevalent diseases group throughout a CAR-T lifecycle to improve CAR-T specific patient centricity
- Outline the real time methods used to overcome challenges to ensure clear and transparent interaction of patient groups
3:15 pm Understanding the Differences Between Prevalent & Rare Diseases to Optimize Tailored Patient Educational Materials
Synopsis
- Contrasting the challenges of prevalent and rare diseases to validate potential educational approaches for each disease type.
- Learning new methodologies of creating educational materials to optimize patient transparency
- Addressing cell and gene specific patient insights to improve patient education materials